FDA Amendment to Include Vitamin D in Osteoporosis Claims

Effective January 1, 2010, the Food and Drug Administration (FDA) amended its label regulation authorizing a health claim on the relationship between calcium and a reduced risk of osteoporosis to include vitamin D.

Manufacturers will be able, under these new rules, to recreate product labels to add health claims to their products that qualify or reformulate products (by fortifying with calcium or vitamin D) to qualify for the health claims.

The FDA solicited comments on the calcium and vitamin D proposed rule, with the comment period closing on March 21, 2007.